查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2020527

全球透明質酸市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Hyaluronic Acid Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年，透明質酸市場規模將達到 120.8 億美元，高於 2025 年的 62.9 億美元，預計從 2026 年到 2034 年的複合年成長率將達到 7.52%。

由於在化妝品、藥品和醫療領域的應用日益廣泛，全球透明質酸市場正經歷穩定成長。透明質酸因其卓越的保濕和抗衰老功效而被廣泛應用於護膚產品中。在醫療領域，它常用於皮膚填充、骨關節炎注射和眼科手術。消費者對護膚和美容護理意識的不斷提高，顯著推動了已開發國家和新興市場市場的擴張。

推動該市場發展的主要因素之一是人們對微創美容手術日益成長的需求。含有透明質酸的皮膚填充劑廣泛用於臉部回春、減少皺紋和豐唇。此外，骨關節炎等關節疾病的日益普遍也促進了用於關節內粘稠補充療法的透明質酸注射劑的需求。美容和個人護理行業的快速擴張也是推動市場成長的重要因素。

隨著研發活動的不斷推進，透明質酸的應用領域持續拓展，預計市場將迎來強勁成長。生物技術和發酵生產流程的創新正在提升產品品質並降低生產成本。隨著市場對先進美容療法和再生醫學解決方案的需求不斷成長，透明質酸市場預計在未來幾年將顯著發展。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球玻尿酸市場：依產品分類

  • 市場分析、洞察與預測
  • 多劑量
  • 單一劑量

第5章 全球玻尿酸市場：依應用領域分類

  • 市場分析、洞察與預測
  • 骨關節炎
  • 皮膚填充劑
  • 眼科
  • 膀胱輸尿管逆流
  • 其他用途

第6章：全球玻尿酸市場：依等級分類

  • 市場分析、洞察與預測
  • 藥用級玻尿酸
  • 化妝品級玻尿酸

第7章：全球玻尿酸市場：依來源分類

  • 市場分析、洞察與預測
  • 非鳥類起源
  • 鳥類起源

第8章：全球透明質酸市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 整形外科診所
  • 其他最終用途

第9章 全球玻尿酸市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Roche
    • Sanofi
    • LG Chem Ltd
    • Galderma
    • Ferring Pharmaceuticals
    • Allergan Aesthetics（an AbbVie Company）
    • Seikagaku Corporation
    • Bioventus LLC
    • Anika Therapeutics Inc
    • Lifecore Biomedical
    • Bloomage Biotechnology Corporation Limited
    • Teleflex Incorporated（Deflux Brand）
    • Kewpie Corporation
    • Altergon Italia Srl
    • Topscience Co. Ltd
簡介目錄
Product Code: VMR112115375

The Hyaluronic Acid Market size is expected to reach USD 12.08 Billion in 2034 from USD 6.29 Billion (2025) growing at a CAGR of 7.52% during 2026-2034.

The global hyaluronic acid market is experiencing steady growth due to its increasing use in cosmetics, pharmaceuticals, and medical treatments. Hyaluronic acid is widely used in skincare products for its excellent moisturizing and anti-aging properties. In the healthcare sector, it is commonly used in dermal fillers, osteoarthritis injections, and ophthalmic surgeries. Rising consumer awareness about skincare and aesthetic treatments has significantly contributed to the market's expansion across developed and emerging economies.

One of the key drivers of this market is the growing demand for minimally invasive cosmetic procedures. Dermal fillers containing hyaluronic acid are widely used for facial rejuvenation, wrinkle reduction, and lip enhancement. Additionally, the increasing prevalence of joint disorders such as osteoarthritis has boosted the demand for hyaluronic acid injections used in viscosupplementation therapies. The rapid expansion of the beauty and personal care industry is also playing an important role in driving market growth.

Looking ahead, the market is expected to witness strong growth as research and development activities continue to expand the application areas of hyaluronic acid. Innovations in biotechnology and fermentation-based production methods are improving product quality and reducing manufacturing costs. With increasing demand for advanced aesthetic treatments and regenerative medicine solutions, the hyaluronic acid market is projected to grow significantly in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Multiple Injection Dose
  • Single Injection Dose

By Application

  • Osteoarthritis
  • Dermal Fillers
  • Ophthalmic
  • Vesicoureteral Reflux
  • Other Applications

By Grade

  • Pharmaceutical Grade Hyaluronic Acid
  • Cosmetic Grade Hyaluronic Acid

By Source of Origin

  • Non-avian Origin
  • Avian Origin

By End Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Orthopedic Clinics
  • Other End Use

COMPANIES PROFILED

  • Roche, Sanofi, LG Chem Ltd, Galderma, Ferring Pharmaceuticals, Allergan Aesthetics an AbbVie company, Seikagaku Corporation, Bioventus LLC, Anika Therapeutics Inc, Lifecore Biomedical, Bloomage Biotechnology Corporation Limited, Teleflex Incorporated Deflux brand, Kewpie Corporation, Altergon Italia Srl, Topscience Co Ltd
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HYALURONIC ACID MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Multiple Injection Dose Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Single Injection Dose Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HYALURONIC ACID MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Osteoarthritis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Dermal Fillers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Ophthalmic Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Vesicoureteral Reflux Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HYALURONIC ACID MARKET: BY GRADE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Grade
  • 6.2. Pharmaceutical Grade Hyaluronic Acid Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Cosmetic Grade Hyaluronic Acid Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HYALURONIC ACID MARKET: BY SOURCE OF ORIGIN 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Source Of Origin
  • 7.2. Non-avian Origin Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Avian Origin Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HYALURONIC ACID MARKET: BY END USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End Use
  • 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Orthopedic Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Other End Use Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL HYALURONIC ACID MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Product
    • 9.2.2 By Application
    • 9.2.3 By Grade
    • 9.2.4 By Source Of Origin
    • 9.2.5 By End Use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Product
    • 9.3.2 By Application
    • 9.3.3 By Grade
    • 9.3.4 By Source Of Origin
    • 9.3.5 By End Use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Product
    • 9.4.2 By Application
    • 9.4.3 By Grade
    • 9.4.4 By Source Of Origin
    • 9.4.5 By End Use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Product
    • 9.5.2 By Application
    • 9.5.3 By Grade
    • 9.5.4 By Source Of Origin
    • 9.5.5 By End Use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Product
    • 9.6.2 By Application
    • 9.6.3 By Grade
    • 9.6.4 By Source Of Origin
    • 9.6.5 By End Use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL HYALURONIC ACID INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Roche
    • 11.2.2 Sanofi
    • 11.2.3 LG Chem Ltd
    • 11.2.4 Galderma
    • 11.2.5 Ferring Pharmaceuticals
    • 11.2.6 Allergan Aesthetics (an AbbVie Company)
    • 11.2.7 Seikagaku Corporation
    • 11.2.8 Bioventus LLC
    • 11.2.9 Anika Therapeutics Inc
    • 11.2.10 Lifecore Biomedical
    • 11.2.11 Bloomage Biotechnology Corporation Limited
    • 11.2.12 Teleflex Incorporated (Deflux Brand)
    • 11.2.13 Kewpie Corporation
    • 11.2.14 Altergon Italia S.r.l
    • 11.2.15 Topscience Co. Ltd